Pfizer Inc.:戦略・SWOT・企業財務分析

MarketLineが発行した調査報告書(DATA8014968)
◆英語タイトル:Pfizer Inc. - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA8014968
◆発行会社(リサーチ会社):MarketLine
◆発行日:2017年9月30日
◆ページ数:79
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD175 ⇒換算¥19,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥38,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥57,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。MarketLine社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Pfizer Inc. – Strategy, SWOT and Corporate Finance Report
Summary

Pfizer Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Pfizer (or ‘the company’) is a research-based, global biopharmaceutical company. Its portfolio includes medicines, vaccines and consumer products. The company operates in several countries across the globe. It is headquartered in New York City, New York.

Scope

- Detailed information on Pfizer Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Pfizer Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Pfizer Inc. including a breakdown and examination of key business segments
- Intelligence on Pfizer Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Pfizer Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Pfizer Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Pfizer Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Pfizer Inc.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Pfizer Inc.: Company Overview
Pfizer Inc.: Overview and Key Facts
Pfizer Inc.: Overview
Pfizer Inc.: Key Facts
Pfizer Inc.: Key Employees
Pfizer Inc.: Key Employee Biographies
Pfizer Inc.: Major Products and Services
Pfizer Inc.: Company History
Pfizer Inc.: Management Statement
Pfizer Inc.: Locations and Subsidiaries
Pfizer Inc.: Key Competitors
Pfizer Inc.: Company Analysis
Pfizer Inc.: Business Description
Pfizer Inc.: SWOT Analysis
Pfizer Inc.: SWOT Overview
Pfizer Inc.: Strengths
Pfizer Inc.: Weaknesses
Pfizer Inc.: Opportunities
Pfizer Inc.: Threats
Pfizer Inc.: Corporate Financial Deals Activity
Pfizer Inc.: Financial Deals Overview
Pfizer Inc.: Targets and Partners
Pfizer Inc.: Top Deals 2013 – 2017YTD*
Pfizer Inc.: Advisors
Pfizer Inc.: Top Legal Advisors
Pfizer Inc.: Top Financial Advisors
Pfizer Inc.: Mergers and Acquisitions
Pfizer Inc.: Corporate Venturing
Pfizer Inc.: Partnership
Pfizer Inc.: Divestments
Pfizer Inc.: Recent Developments
Pfizer Inc.: News and Events Summary
Pfizer Inc.: Contracts
Pfizer Inc.: Corporate Governance
Pfizer Inc.: IT Spending Announcements
Pfizer Inc.: Market Developments
Pfizer Inc.: Research & Development
Pfizer Inc.: Strategy and Operations
Appendix
Contact Us
Methodology
Definitions
About MarketLine

List of Tables
Table 1: Pfizer Inc.: Key Facts
Table 2: Pfizer Inc.: Key Employees
Table 3: Pfizer Inc.: Locations and Subsidiaries
Table 4: Pfizer Inc.: Key Competitors
Table 5: Pfizer Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Pfizer Inc.: M&A Activity by Geography (TTM*)
Table 7: Pfizer Inc.: Deal Activity by Deal Type - Volume (2013 - YTD*2017)
Table 8: Pfizer Inc.: M&A Average Deal Size - Value (US$m)
Table 9: Pfizer Inc.: Targets and Partners
Table 10: Pfizer Inc.: Top Deals 2013 - 2017YTD*
Table 11: Pfizer Inc.: Legal Advisor Ranking by Value (US$m)
Table 12: Pfizer Inc.: Financial Advisor Ranking by Value (US$m)
Table 13: Pfizer Inc.: M&A Volume and Value Trend (2013 - YTD*2017)
Table 14: Pfizer Inc.: M&A Activity by Geography (2013 - YTD*2017)
Table 15: Pfizer Inc.: Corporate Venturing Volume and Value Trend (2013 - YTD*2017)
Table 16: Pfizer Inc.: Corporate Venturing by Geography (2013 - YTD*2017)
Table 17: Pfizer Inc.: Partnership Volume and Value Trend (2013 - YTD*2017)
Table 18: Pfizer Inc.: Partnership Trend by Deal Type (2013 - YTD*2017)
Table 19: Pfizer Inc.: Divestments Volume and Value Trend (2013 - YTD*2017)
Table 20: Pfizer Inc.: Divestments by Geography (2013 - YTD*2017)
Table 21: Pfizer Inc.: News and Events Summary
Table 22: Pfizer Inc.: Contracts
Table 23: Pfizer Inc.: Corporate Governance
Table 24: Pfizer Inc.: IT Spending Announcements
Table 25: Pfizer Inc.: Market Developments
Table 26: Pfizer Inc.: Research & Development
Table 27: Pfizer Inc.: Strategy and Operations

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ Pfizer Inc.:戦略・SWOT・企業財務分析(Pfizer Inc. - Strategy, SWOT and Corporate Finance Report)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆